May trade under 0.20 today its seems , which is 1 cent old sp , over $1.5 million receivables , orphan drug application in March quarter means nothing to the market , seems just no confidence in the current team , lead by the same CEO since 2007 .
Cellmid really should at least try a different approach , anything is worth a try .
Investors are really being hit extremely hard here .
Ann: Midkine Symposium Munich, page-74
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
